PYXIS ONCOLOGY

Stock
Options
Trade PYXS
PYXS Insider Trades:
Created with Highcharts 10.1.0PriceVolumeJan '22May '22Sep '22Jan '23May '23Sep '23Jan '24May '24Sep '24Jan '25May '25-40481216200400k800k1 200k1 600k2 000k2 400k






Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
Director
10% Owner
Mcap/AUM
2025-04-21
2025-04-21
HUMPHREY RACHEL
S - Sale
-13,896
$1.00
-13,896
1
$83.63M
2025-04-17
2025-04-17
HUMPHREY RACHEL
S - Sale
-200
$1.00
-200
1
$83.63M
2025-04-14
2025-04-14
HUMPHREY RACHEL
S - Sale
-1,400
$1.00
-1,400
1
$83.63M
2025-03-31
2025-04-02
CONNEALY PAMELA ANN
CFO & COO
A - Grant
Stock Option (Right to Buy)
414K
$1.00
414K
1
$83.63M
2025-03-31
2025-04-02
DUPONT JAKOB
A - Grant
Stock Option (Right to Buy)
36,979
$1.00
36,979
1
$83.63M
2025-03-31
2025-04-02
FLAVIN JOHN
A - Grant
Stock Option (Right to Buy)
36,979
$1.00
36,979
1
$83.63M
2025-03-31
2025-04-02
HUMPHREY RACHEL
A - Grant
Stock Option (Right to Buy)
36,979
$1.00
36,979
1
$83.63M
2025-03-31
2025-04-02
LEWIS-HALL FREDA
A - Grant
Stock Option (Right to Buy)
36,979
$1.00
36,979
1
$83.63M
2025-03-31
2025-04-02
METZGER MICHAEL
A - Grant
Stock Option (Right to Buy)
36,979
$1.00
36,979
1
$83.63M
2025-03-31
2025-04-02
PALANI SANTHOSH
A - Grant
Stock Option (Right to Buy)
36,979
$1.00
36,979
1
$83.63M
2025-03-31
2025-04-02
SULLIVAN LARA
President ,CEO & CMO
A - Grant
Stock Option (Right to Buy)
918K
$1.00
918K
1
$83.63M
2025-03-31
2025-04-02
WADHANE JITENDRA
SVP, Chief Accounting Officer
A - Grant
Stock Option (Right to Buy)
264K
$1.00
264K
1
$83.63M
2025-03-31
2025-04-02
CIVIK THOMAS
A - Grant
Stock Option (Right to Buy)
36,979
$1.00
36,979
1
$83.63M
2025-03-31
2025-04-02
CONNEALY PAMELA ANN
CFO & COO
A - Grant
Stock Option (Right to Buy)
414K
$1.00
414K
1
$83.63M
2025-03-31
2025-04-02
DUPONT JAKOB
A - Grant
Stock Option (Right to Buy)
36,979
$1.00
36,979
1
$83.63M
2025-03-31
2025-04-02
FLAVIN JOHN
A - Grant
Stock Option (Right to Buy)
36,979
$1.00
36,979
1
$83.63M
2025-03-31
2025-04-02
HUMPHREY RACHEL
A - Grant
Stock Option (Right to Buy)
36,979
$1.00
36,979
1
$83.63M
2025-03-31
2025-04-02
LEWIS-HALL FREDA
A - Grant
Stock Option (Right to Buy)
36,979
$1.00
36,979
1
$83.63M
2025-03-31
2025-04-02
METZGER MICHAEL
A - Grant
Stock Option (Right to Buy)
36,979
$1.00
36,979
1
$83.63M
2025-03-31
2025-04-02
PALANI SANTHOSH
A - Grant
Stock Option (Right to Buy)
36,979
$1.00
36,979
1
$83.63M
2025-03-31
2025-04-02
SULLIVAN LARA
President ,CEO & CMO
A - Grant
Stock Option (Right to Buy)
918K
$1.00
918K
1
$83.63M
2025-03-31
2025-04-02
WADHANE JITENDRA
SVP, Chief Accounting Officer
A - Grant
Stock Option (Right to Buy)
264K
$1.00
264K
1
$83.63M
2025-03-31
2025-04-02
CLINE DARREN
A - Grant
Stock Option (Right to Buy)
36,979
$1.00
36,979
1
$83.63M
2025-03-31
2025-04-02
CIVIK THOMAS
A - Grant
Stock Option (Right to Buy)
36,979
$1.00
36,979
1
$83.63M
2025-03-31
2025-04-02
CLINE DARREN
A - Grant
Stock Option (Right to Buy)
36,979
$1.00
36,979
1
$83.63M
2024-12-23
2024-12-23
CONNEALY PAMELA ANN
CFO & COO
A - Grant
Stock Option (Right to Buy)
310K
$0.00
1
$83.63M
2024-12-23
2024-12-23
SULLIVAN LARA
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
1.14M
$0.00
1
$83.63M
2024-12-23
2024-12-23
WADHANE JITENDRA
SVP, Chief Accounting Officer
A - Grant
Stock Option (Right to Buy)
150K
$0.00
1
$83.63M
2024-11-26
2024-11-27
CONNEALY PAMELA ANN
CFO & COO
P - Purchase
Common Stock
88,850
$2.00
178K
2
$83.63M
2024-06-10
2024-06-10
METZGER MICHAEL
A - Grant
Stock Option (Right to Buy)
70,683
$0.00
1
$83.63M
2024-06-07
2024-06-07
PALANI SANTHOSH
A - Grant
Common Stock
6,000
$0.00
1
$83.63M
2024-03-26
2024-03-28
CONNEALY PAMELA ANN
CFO & COO
A - Grant
Common Stock
329K
$0.00
1
$83.63M
2024-03-26
2024-03-28
CIVIK THOMAS
A - Grant
Stock Option (Right to Buy)
44,024
$4.00
176K
1
$83.63M
2024-03-26
2024-03-28
CLINE DARREN
A - Grant
Common Stock
35,219
$0.00
1
$83.63M
2024-03-26
2024-03-28
DUPONT JAKOB
A - Grant
Common Stock
38,741
$0.00
1
$83.63M
2024-03-26
2024-03-28
FLAVIN JOHN
A - Grant
Common Stock
35,219
$0.00
1
$83.63M
2024-03-26
2024-03-28
HUMPHREY RACHEL
A - Grant
Common Stock
38,741
$0.00
1
$83.63M
2024-03-26
2024-03-28
LEWIS-HALL FREDA
A - Grant
Common Stock
35,219
$0.00
1
$83.63M
2024-03-26
2024-03-28
SULLIVAN LARA
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
1.07M
$4.00
4.28M
1
$83.63M
2024-03-26
2024-03-28
WADHANE JITENDRA
SVP, Chief Accounting Officer
A - Grant
Common Stock
131K
$0.00
1
$83.63M
2024-03-12
2024-03-13
PALANI SANTHOSH
A - Grant
Stock Option (Right to Buy)
69,760
$0.00
1
$83.63M
2023-12-29
2023-12-29
KOBAYASHI KEN
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
554K
$0.00
2
$83.63M
2023-11-29
2023-11-30
CONNEALY PAMELA ANN
CFO and COO
F - Tax
Common Stock
-36,949
$1.00
-36,949
1
$83.63M
2023-11-15
2023-11-17
WADHANE JITENDRA
Chief Accounting Officer
A - Grant
Common Stock
40,000
$0.00
1
$83.63M
2023-09-28
2023-09-28
CONNEALY PAMELA ANN
CFO and COO
P - Purchase
Common Stock
8,000
$2.00
16,000
1
$83.63M
2023-09-27
2023-09-27
CONNEALY PAMELA ANN
CFO and COO
P - Purchase
Common Stock
6,426
$2.00
12,852
1
$83.63M
2023-09-27
2023-09-27
WADHANE JITENDRA
Chief Accounting Officer
P - Purchase
Common Stock
2,500
$2.00
5,000
1
$83.63M
2023-09-22
2023-09-26
DUPONT JAKOB
A - Grant
Stock Option (Right to Buy)
392K
$0.00
1
$83.63M
2023-09-25
2023-09-25
CONNEALY PAMELA ANN
CFO and COO
P - Purchase
Common Stock
12,000
$2.00
24,000
1
$83.63M
2023-09-25
2023-09-25
WADHANE JITENDRA
Chief Accounting Officer
P - Purchase
Common Stock
5,000
$2.00
10,000
1
$83.63M
2023-09-22
2023-09-22
CONNEALY PAMELA ANN
CFO and COO
P - Purchase
Common Stock
5,000
$2.00
10,000
1
$83.63M
2023-09-22
2023-09-22
WADHANE JITENDRA
Chief Accounting Officer
P - Purchase
Common Stock
2,500
$2.00
5,000
1
$83.63M
2023-09-18
2023-09-18
SULLIVAN LARA
President and CEO
S - Sale
Common Stock
-8,541
$2.00
-17,082
1
$83.63M
2023-09-14
2023-09-18
SULLIVAN LARA
President and CEO
S - Sale
Common Stock
-100
$2.00
-200
1
$83.63M
2023-09-13
2023-09-13
SULLIVAN LARA
President and CEO
F - Tax
Common Stock
-185K
$2.00
-369K
1
$83.63M
2023-09-13
2023-09-13
SULLIVAN LARA
President and CEO
S - Sale
Common Stock
-3,000
$2.00
-6,000
1
$83.63M
2023-09-12
2023-09-13
SULLIVAN LARA
President and CEO
S - Sale
Common Stock
-4,917
$2.00
-9,834
1
$83.63M
2023-09-11
2023-09-13
SULLIVAN LARA
President and CEO
S - Sale
Common Stock
-20,000
$2.00
-40,000
1
$83.63M
2023-09-07
2023-09-08
SULLIVAN LARA
President and CEO
A - Grant
Common Stock
469K
$0.00
1
$83.63M
2023-09-07
2023-09-08
CONNEALY PAMELA ANN
CFO and COO
A - Grant
Common Stock
188K
$0.00
1
$83.63M
2023-09-07
2023-09-08
WADHANE JITENDRA
Chief Accounting Officer
A - Grant
Common Stock
93,896
$0.00
1
$83.63M
2023-09-05
2023-09-05
FEINGOLD JAY
Chief Medical Officer
S - Sale
-18,109
$2.00
-36,218
1
$83.63M
2023-08-23
2023-08-25
DUPONT JAKOB
A - Grant
Stock Option (Right to buy)
26,663
3
$83.63M
2023-08-11
2023-08-11
FEINGOLD JAY
Chief Medical Officer
S - Sale
-50,000
$3.00
-150K
1
$83.63M
2023-08-01
2023-08-01
FEINGOLD JAY
Chief Medical Officer
S - Sale
-25,000
$3.00
-75,000
1
$83.63M
2023-07-31
2023-07-31
FEINGOLD JAY
Chief Medical Officer
S - Sale
-25,000
$3.00
-75,000
1
$83.63M
2023-07-27
2023-07-28
FEINGOLD JAY
Chief Medical Officer
S - Sale
-23,021
$2.00
-46,042
1
$83.63M
2023-07-27
2023-07-27
FEINGOLD JAY
Chief Medical Officer
S - Sale
-23,021
$2.00
-46,042
1
$83.63M
2023-07-21
2023-07-21
FEINGOLD JAY
Chief Medical Officer
S - Sale
-27,361
$3.00
-82,083
1
$83.63M
2023-07-11
2023-07-11
FEINGOLD JAY
Chief Medical Officer
S - Sale
-30,000
$3.00
-90,000
1
$83.63M
2023-06-16
2023-06-16
FEINGOLD JAY
Chief Medical Officer
S - Sale
-234
$3.00
-702
1
$83.63M
2023-06-08
2023-06-08
FEINGOLD JAY
Chief Medical Officer
S - Sale
-23,637
$3.00
-70,911
1
$83.63M
2023-06-07
2023-06-07
FEINGOLD JAY
Chief Medical Officer
S - Sale
-37,402
$3.00
-112K
1
$83.63M
2023-03-24
2023-03-28
CIVIK THOMAS
A - Grant
Common Stock
139K
$0.00
1
$83.63M
2023-03-24
2023-03-28
CLINE DARREN
A - Grant
Common Stock
139K
$0.00
1
$83.63M
2023-03-24
2023-03-28
FEINGOLD JAY
Chief Medical Officer
A - Grant
Stock Option (Right to buy)
175K
2
$83.63M
2023-03-24
2023-03-28
FEINGOLD JAY
Chief Medical Officer
A - Grant
Common Stock
210K
$0.00
1
$83.63M
2023-03-24
2023-03-28
FLAVIN JOHN
A - Grant
Common Stock
139K
$0.00
1
$83.63M
2023-03-24
2023-03-28
HUMPHREY RACHEL
A - Grant
Common Stock
58,064
$0.00
1
$83.63M
2023-03-24
2023-03-28
LEWIS-HALL FREDA
A - Grant
Common Stock
139K
$0.00
1
$83.63M
2023-03-24
2023-03-28
SULLIVAN LARA
President and CEO
A - Grant
Stock Option (Right to buy)
1.05M
2
$83.63M
2023-03-24
2023-03-28
SULLIVAN LARA
President and CEO
A - Grant
Common Stock
703K
$0.00
1
$83.63M
2023-03-24
2023-03-28
WADHANE JITENDRA
Chief Accounting Officer
A - Grant
Stock Option (Right to buy)
157K
1
$83.63M
2023-03-24
2023-03-28
WADHANE JITENDRA
Chief Accounting Officer
A - Grant
Common Stock
74,393
$0.00
2
$83.63M
2023-03-24
2023-03-28
YANCHIK CONNEALY PAMELA
CFO and COO
A - Grant
Stock Option (Right to buy)
333K
2
$83.63M
2023-03-24
2023-03-28
YANCHIK CONNEALY PAMELA
CFO and COO
A - Grant
Common Stock
210K
$0.00
1
$83.63M
2023-03-24
2023-03-28
FEINGOLD JAY
Chief Medical Officer
D - Sale to Issuer
Stock Option (Right to buy)
-175K
2
$83.63M
2023-03-24
2023-03-28
SULLIVAN LARA
President and CEO
D - Sale to Issuer
Stock Option (Right to buy)
-1.05M
2
$83.63M
2023-03-24
2023-03-28
WADHANE JITENDRA
Chief Accounting Officer
D - Sale to Issuer
Stock Option (Right to buy)
-157K
1
$83.63M
2023-03-24
2023-03-28
YANCHIK CONNEALY PAMELA
CFO and COO
D - Sale to Issuer
Stock Option (Right to buy)
-333K
2
$83.63M
2023-03-17
2023-03-23
PFIZER INC
P - Purchase
Common Stock, $0.001 par value per share
1.81M
$3.00
5.43M
1
$83.63M
2023-03-17
2023-03-21
PFIZER INC
P - Purchase
Common Stock, $0.001 par value per share
1.81M
$3.00
5.43M
1
$83.63M
2023-01-03
2023-01-03
FEINGOLD JAY
Chief Medical Officer
A - Grant
Common Stock
53,931
$0.00
1
$83.63M
2023-01-03
2023-01-03
SULLIVAN LARA
Chief Executive Officer
A - Grant
Common Stock
95,684
$0.00
1
$83.63M
2023-01-03
2023-01-03
YANCHIK CONNEALY PAMELA
Chief Financial Officer
A - Grant
Common Stock
43,493
$0.00
1
$83.63M
2022-08-11
2022-08-15
HUMPHREY RACHEL
A - Grant
Stock Option (Right to Buy)
236K
$0.00
1
$83.63M
2022-04-21
2022-04-25
CHIN MARK
S - Sale
Common Stock
-1.75M
$3.00
-5.24M
1
$83.63M
2022-04-14
2022-04-15
FEINGOLD JAY
Chief Medical Officer
A - Grant
Common Stock
116K
$0.00
1
$83.63M
2022-04-14
2022-04-15
SULLIVAN LARA
Chief Executive Officer
A - Grant
Common Stock
315K
$0.00
1
$83.63M
2022-04-14
2022-04-15
YANCHIK CONNEALY PAMELA
Chief Financial Officer
A - Grant
Common Stock
93,493
$0.00
1
$83.63M
2022-03-31
2022-04-04
CHIN MARK
A - Grant
Common Stock
66,831
$0.00
1
$83.63M
2022-03-31
2022-04-04
CIVIK THOMAS
A - Grant
Common Stock
66,831
$0.00
1
$83.63M
2022-03-31
2022-04-04
CLINE DARREN
A - Grant
Common Stock
66,831
$0.00
1
$83.63M
2022-03-31
2022-04-04
FEINGOLD JAY
Chief Medical Officer
A - Grant
Common Stock
307K
$0.00
1
$83.63M
2022-03-31
2022-04-04
FLAVIN JOHN
A - Grant
Common Stock
66,831
$0.00
1
$83.63M
2022-03-31
2022-04-04
LEWIS-HALL FREDA
A - Grant
Common Stock
66,831
$0.00
1
$83.63M
2022-03-31
2022-04-04
SULLIVAN LARA
Chief Executive Officer
A - Grant
Common Stock
743K
$0.00
1
$83.63M
2022-03-31
2022-04-04
YANCHIK CONNEALY PAMELA
Chief Financial Officer
A - Grant
Common Stock
248K
$0.00
1
$83.63M
2021-12-08
2021-12-09
CLINE DARREN
P - Purchase
Common Stock
10,000
$9.00
90,000
1
$83.63M
2021-12-06
2021-12-07
YANCHIK CONNEALY PAMELA
Chief Financial Officer
A - Grant
Stock Option (Right to buy)
52,944
$0.00
1
$83.63M
2021-11-18
2021-11-19
CIVIK THOMAS
P - Purchase
Common Stock
15,700
$13.00
204K
1
$83.63M
2021-10-13
2021-10-15
BAYER WORLD INVESTMENTS B.V.
C - Conversion
Series A Convertible Preferred Stock
-11M
1
$83.63M
2021-10-13
2021-10-15
BAYER WORLD INVESTMENTS B.V.
C - Conversion
Series B Convertible Preferred Stock
-6.08M
1
$83.63M
2021-10-13
2021-10-15
BAYER WORLD INVESTMENTS B.V.
C - Conversion
Common Stock
2.74M
1
$83.63M
2021-10-13
2021-10-15
CHIN MARK
C - Conversion
Series B Convertible Preferred Stock
-9.11M
$0.00
1
$83.63M
2021-10-13
2021-10-15
CHIN MARK
C - Conversion
Common Stock
1.43M
1
$83.63M
2021-10-13
2021-10-15
CORMORANT ASSET MANAGEMENT, LP
C - Conversion
Series B Convertible Preferred Stock
-669K
1
$83.63M
2021-10-13
2021-10-15
CORMORANT ASSET MANAGEMENT, LP
C - Conversion
Common Stock
669K
1
$83.63M
2021-10-13
2021-10-15
FLAVIN JOHN
C - Conversion
Series B Convertible Preferred Stock
-15,190
$0.00
1
$83.63M
2021-10-13
2021-10-15
FLAVIN JOHN
C - Conversion
Common Stock
2,388
1
$83.63M
2021-10-13
2021-10-15
CHIN MARK
P - Purchase
Common Stock
313K
$16.00
5.00M
1
$83.63M
2021-10-13
2021-10-15
CORMORANT ASSET MANAGEMENT, LP
P - Purchase
Common Stock
450K
$16.00
7.20M
1
$83.63M
2021-10-07
2021-10-12
CHIN MARK
A - Grant
Stock Option (Right to buy)
42,191
$0.00
1
$83.63M
2021-10-07
2021-10-12
CIVIK THOMAS
A - Grant
Stock Option (Right to buy)
42,191
$0.00
1
$83.63M
2021-10-07
2021-10-12
CLINE DARREN
A - Grant
Stock Option (Right to buy)
42,191
$0.00
1
$83.63M
2021-10-07
2021-10-12
FEINGOLD JAY
Chief Medical Officer
A - Grant
Stock Option (Right to buy)
437K
$0.00
1
$83.63M
2021-10-07
2021-10-12
FEINGOLD JAY
Chief Medical Officer
A - Grant
Common Stock
43,750
$0.00
1
$83.63M
2021-10-07
2021-10-12
FLAVIN JOHN
A - Grant
Stock Option (Right to buy)
42,191
$0.00
1
$83.63M
2021-10-07
2021-10-12
HERBST RONALD
Chief Scientific Officer
A - Grant
Stock Option (Right to buy)
28,252
$0.00
1
$83.63M
2021-10-07
2021-10-12
LEWIS-HALL FREDA
A - Grant
Stock Option (Right to buy)
42,191
$0.00
1
$83.63M
2021-10-07
2021-10-12
SHAH RITU
Chief Operating Officer
A - Grant
Stock Option (Right to buy)
31,344
$0.00
1
$83.63M
2021-10-07
2021-10-12
SULLIVAN LARA
Chief Executive Officer
A - Grant
Stock Option (Right to buy)
962K
$0.00
1
$83.63M